NCT04915183 2026-03-09
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Gustave Roussy, Cancer Campus, Grand Paris
Medical University of Bialystok
Peking University People's Hospital